iBio (IBIO) Enterprise Value (2010 - 2026)
iBio (IBIO) posted quarterly Enterprise Value of -$74.8 million for Q1 2026, down 1396.36% year-over-year from $5.8 million in Q1 2025, and down 42.0% quarter-over-quarter from -$52.7 million in Q4 2025.
iBio (IBIO) Enterprise Value (2010 - 2026) Analysis & Trends
iBio (IBIO) has reported Enterprise Value for 17 consecutive years, with -$74.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 1396.36% year-over-year to -$74.8 million; the TTM figure through Mar 2026 stood at -$74.8 million (down 1396.36% YoY), while the FY2025 annual figure was -$8.6 million, up 39.61% from the prior year.
- Enterprise Value slipped to -$74.8 million in Q1 2026 per IBIO's latest filing, from -$52.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$3.8 million in Q4 2023 and bottomed at -$74.8 million in Q1 2026.
- Historically, Enterprise Value has averaged -$20.6 million across 5 years, with a median of -$8.6 million in 2025.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 87.22% — and 2026, when it slumped 1396.36%.
- iBio's Enterprise Value stood at -$6.0 million in 2022, then soared by 35.46% to -$3.8 million in 2023, then sank by 82.44% to -$7.0 million in 2024, then sank by 651.08% to -$52.7 million in 2025, then plunged by 42.0% to -$74.8 million in 2026.
- Business Quant data shows IBIO's Enterprise Value at -$74.8 million in Q1 2026, -$52.7 million in Q4 2025, and -$49.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 2.12 Bn |
| 10 | iBio | 173.18 Mn | 173.18 Mn | - | -74.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.82 Mn |
| Dec 31, 2025 | -52.69 Mn |
| Sep 30, 2025 | -49.61 Mn |
| Jun 30, 2025 | -8.58 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | -7.02 Mn |
| Sep 30, 2024 | -11.00 Mn |
| Jun 30, 2024 | -14.21 Mn |
| Mar 31, 2024 | -6.22 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Sep 30, 2023 | -4.51 Mn |
| Jun 30, 2023 | -7.33 Mn |
| Mar 31, 2023 | -6.56 Mn |
| Dec 31, 2022 | -5.96 Mn |
| Sep 30, 2022 | -15.23 Mn |
| Jun 30, 2022 | -33.52 Mn |
| Mar 31, 2022 | -43.26 Mn |
| Dec 31, 2021 | -46.61 Mn |
| Sep 30, 2021 | -71.71 Mn |
| Jun 30, 2021 | -96.99 Mn |